PETX
Citadel Advisors’s Aratana Therapeutics, Inc. PETX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-30,557
| Closed | -$158K | – | 5431 |
|
|
2019
Q2 | $158K | Sell |
30,557
-8,791
| -22% | -$45.5K | ﹤0.01% | 4184 |
|
|
2019
Q1 | $142K | Sell |
39,348
-31,418
| -44% | -$113K | ﹤0.01% | 4035 |
|
|
2018
Q4 | $434K | Buy |
70,766
+22,423
| +46% | +$138K | ﹤0.01% | 3358 |
|
|
2018
Q3 | $282K | Sell |
48,343
-17,279
| -26% | -$101K | ﹤0.01% | 3530 |
|
|
2018
Q2 | $279K | Sell |
65,622
-32,197
| -33% | -$137K | ﹤0.01% | 3483 |
|
|
2018
Q1 | $432K | Buy |
97,819
+29,061
| +42% | +$128K | ﹤0.01% | 3029 |
|
|
2017
Q4 | $362K | Buy |
68,758
+2,704
| +4% | +$14.2K | ﹤0.01% | 3027 |
|
|
2017
Q3 | $405K | Buy |
66,054
+8,237
| +14% | +$50.5K | ﹤0.01% | 2806 |
|
|
2017
Q2 | $418K | Buy |
57,817
+6,256
| +12% | +$45.2K | ﹤0.01% | 2694 |
|
|
2017
Q1 | $273K | Buy |
+51,561
| New | +$273K | ﹤0.01% | 2991 |
|
|
2016
Q4 | – | Sell |
-80,547
| Closed | -$754K | – | 4355 |
|
|
2016
Q3 | $754K | Buy |
80,547
+36,348
| +82% | +$340K | ﹤0.01% | 2138 |
|
|
2016
Q2 | $279K | Buy |
44,199
+19,820
| +81% | +$125K | ﹤0.01% | 2598 |
|
|
2016
Q1 | $135K | Sell |
24,379
-120,610
| -83% | -$668K | ﹤0.01% | 2820 |
|
|
2015
Q4 | $809K | Buy |
+144,989
| New | +$809K | ﹤0.01% | 2109 |
|
|
2015
Q1 | – | Sell |
-25,040
| Closed | -$447K | – | 4164 |
|
|
2014
Q4 | $447K | Buy |
25,040
+7,517
| +43% | +$134K | ﹤0.01% | 2623 |
|
|
2014
Q3 | $176K | Buy |
+17,523
| New | +$176K | ﹤0.01% | 2925 |
|